Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Baldi, F. Coni, P. Solidoro, A. Mattei, M. Bardessono (Torino, Italy). Dynamic hyperinflation after bronchial lung volume reduction: An expected effect or perhaps a preoperative test for selection?. Eur Respir J 2013; 42: Suppl. 57, 2283

Member's Comments

No comment yet.

Related content which might interest you: Targeted segmental volume reduction with vapor ablation in emphysema results in reduced RV and clinically meaningful improvement (CMI) in FEV1 Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016 Bronchoscopic lung volume reduction with endobronchial valves improves exercise capacity but not oxygen uptake kinetics in a group of patients with severe emphysema Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases Year: 2013 Patient selection and efficacy of valve bronchoscopic lung volume reduction (BLVR) in emphysema Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Volume changes after segmental vapor ablation and associated improvements in FEV1 Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016 Lung volume reduction coil treatment restores lung compliance in patients with homogeneous emphysema Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Endoscopic lung volume reduction (ELVR) in COPD: Improvements in gas transfer capacity correlate with improvements in ventilation and perfusion (VQ) matching Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015 Echocardiogram parameters in patients with COPD in the year after endoscopic lung volume reduction (ELVR) Source: International Congress 2015 – Bronchoscopic treatment of emphysema and asthma: what is new? Year: 2015 Flow-volume parameters in COPD related to extended measurements of lung volume, diffusion and resistance Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Role of quantitative perfusion scintigraphy evaluation in determination of the efficiency of the procedure before lung volume reduction coil (LVRC) treatment for severe emphysema Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Lung volume reduction for severe emphysema: do we need a scalpel or a scope? Source: Eur Respir Rev 2010 19: 242-247 Year: 2010 Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema Source: Eur Respir J 2012; 39: 1326-1333 Year: 2012 Ability for dynamic hyperinflation increases after bronchoscopic lung volume reduction in patients with severe emphysema. Source: International Congress 2017 – Endoscopic lung volume reduction (EVLR) and targeted lung denervation (TLD) Year: 2017 Targeted vapor ablation as a new method for endoscopic lung volume reduction at segmental level Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016 Endoscopic lung volume reduction in low FEV1 patients Source: International Congress 2016 – Endoscopic lung volume reduction II Year: 2016 The effects of bronchodilators on regional lung sound distribution in patients with COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Endoscopic lung volume reduction (ELVR) in COPD: A comparison between two endobronchial valves systems Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Do all COPD patients present irreversible airflow limitation? Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013 Differential response between cycling and walking test following pulmonary rehabilitation in patients with COPD depends on degree of lung hyperinflation Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases Year: 2015